Division of Infectious Diseases, Department of Medicine, City of Hope National Medical Center, Duarte.
Division of Infectious Diseases and Global Health, University of California, San Diego, La Jolla, CA, USA.
Curr Opin Infect Dis. 2023 Aug 1;36(4):218-227. doi: 10.1097/QCO.0000000000000932. Epub 2023 Jun 12.
PURPOSE OF REVIEW: Our aim is to review recent literature on antibiotic use in patients with neutropenia. RECENT FINDINGS: Prophylactic antibiotics are associated with risks and have limited mortality benefit. While early antibiotic use in febrile neutropenia (FN) is critical, early de-escalation or discontinuation may be safe in many patients. SUMMARY: With an increasing understanding of potential risks and benefits of use and improved risk assessment, paradigms of antibiotic use in neutropenic patients are changing.
目的综述:我们旨在综述中性粒细胞减少症患者抗生素使用的最新文献。
最近发现:预防性使用抗生素存在风险,且对死亡率的获益有限。虽然发热性中性粒细胞减少症(FN)患者早期使用抗生素至关重要,但许多患者早期降阶梯或停药可能是安全的。
总结:随着对抗生素使用潜在风险和获益的认识不断提高,以及风险评估的改善,中性粒细胞减少症患者抗生素使用的模式正在发生变化。
Curr Opin Infect Dis. 2023-8-1
Cochrane Database Syst Rev. 2022-11-28
Cochrane Database Syst Rev. 2012-10-17
J Psychiatr Ment Health Nurs. 2024-8
Cochrane Database Syst Rev. 2013-10-9
Cochrane Database Syst Rev. 2003
Cochrane Database Syst Rev. 2022-10-17
Blood Res. 2025-5-26
Biomedicines. 2025-2-17
Front Public Health. 2024-12-16